At Which Stage of Gastric Cancer Progression Do Levels of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Increase? Application in Advanced Gastric Cancer Treatment
´ëÇÑÀ§¾ÏÇÐȸÁö 2014³â 14±Ç 2È£ p.123 ~ p.128
ÇÑÀǼö(Han Eui-Soo) - Catholic University College of Medicine Department of Surgery
ÀÌÇÑÈ«(Lee Han-Hong) - Catholic University School of Medicine Department of Surgery
ÀÌÁؼ(Lee Jun-Suh) - Catholic University School of Medicine Department of Surgery
¼Û±³¿µ(Song Kyo-Young) - Catholic University School of Medicine Department of Surgery
¹ÚÁ¶Çö(Park Cho-Hyun) - Catholic University School of Medicine Department of Surgery
ÀüÇظí(Jeon Hae-Myung) - Catholic University College of Medicine Department of Surgery
Abstract
Purpose: Since there are no proven tumor markers that reflect the course of gastric cancer, carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are commonly used alternatives. However, the degree of progression that corresponds to an increase in these markers, and the values of these markers at different cancer stages, remains unclear.
Materials and Methods: This study enrolled 1,733 gastric cancer patients who underwent surgery and whose pre-operative CEA and CA19-9 levels were known. Survival curves and mean values of the two markers were compared according to the degree of cancer progression: serosa-unexposed (SU), serosa-exposed (SE), direct invasion (DI), localized seeding (P1), and extensive seeding (P2).
Results: The 5-year overall survival rates at each stage differed significantly, except between DI and P1 patients (17.1% vs. 10.5%, P=0.344). The mean CEA values in SU, SE, DI, P1, and P2 patients were 5.80, 5.48, 13.36, 8.06, and 22.82, respectively. The CA19-9 values for these patients were 49.40, 38.97, 101.67, 73.77, and 98.57, respectively. The increase in CEA in P2 patients was statistically significant (P=0.002), and the increases in CA19-9 in DI and P2 patients were significant (P=0.025, 0.007, respectively). There was a fair correlation between the two markers in P2 patients (r=0.494, P<0.001).
Conclusions: CA19-9 can be used to assess DI of gastric cancer into adjacent organs. Both markers are useful for predicting the presence of extensive peritoneal seeding.
Å°¿öµå
Carcinomatosis, Disease progression, Neoplasm invasiveness, Stomach neoplasms, Tumor markers, biological
KMID :
0914820140140020123
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)